Physician profile
Aimee E Brooken
NPI 1760746788
$1,507.82
in general payments reported to CMS, 2019-2025
19 companies · $215 in 2025
The $215 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.76 · 2020: $91.66 · 2021: $113 · 2022: $371 · 2023: $360 · 2024: $343 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $368.03 | 2022-2025 | Caplyta |
| Novo Nordisk INC | $334.70 | 2019-2025 | Ozempic, Wegovy |
| Pfizer INC. | $104.68 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $99.78 | 2021-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Otsuka America Pharmaceutical, INC. | $64.31 | 2022-2023 | Rexulti, Abilify Maintena |
| Lilly USA, LLC | $63.52 | 2020-2023 | Mounjaro, Basaglar |
| Axsome Therapeutics, INC. | $57.66 | 2024-2025 | Auvelity |
| Exact Sciences Corporation | $56.50 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $56.29 | 2021-2023 | |
| Neurocrine Biosciences, INC. | $47.78 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $45.57 | 2020-2021 | |
| Alkermes, INC. | $42.86 | 2024 | Vivitrol |
| Abbvie INC. | $37.75 | 2023 | |
| Nestle Healthcare Nutrition INC. | $30.07 | 2022 | |
| Idorsia Pharmaceuticals US INC | $24.36 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $20.60 | 2023 | Valtoco |
| Lundbeck LLC | $19.54 | 2020 | |
| Abiomed | $17.26 | 2023 | Impella |
| Glaxosmithkline, LLC. | $16.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Brooken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.